| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/01/2008 | US7393994 Animal model for use in the diagnosis and treatment of nervous system disorders |
| 07/01/2008 | US7393945 Estrogen receptor genes and utilization thereof |
| 07/01/2008 | US7393944 Lymphocytes; transcription factors; interferons |
| 07/01/2008 | US7393943 for the treatment of leukemia, tumors, chronic infections, auto-immune disease, fibrotic disorders, wound healing and psoriasis |
| 07/01/2008 | US7393942 Nucleic acids encoding mutant forms of Fas ligand |
| 07/01/2008 | US7393939 Transport protein for use in the removal of the xenobiotics from mammals |
| 07/01/2008 | US7393935 Method of selective arrangement of ferritin |
| 07/01/2008 | US7393934 Human G-protein chemokine receptor (CCR5) HDGNR10 |
| 07/01/2008 | US7393933 Hepatitis B monoclonal antibodies |
| 07/01/2008 | US7393932 Endothelial cell expression patterns |
| 07/01/2008 | US7393931 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 07/01/2008 | US7393929 Inhibitors of cellulolytic, xylanolytic and β-glucanolytic enzymes |
| 07/01/2008 | US7393928 Recombinant gelatins |
| 07/01/2008 | US7393927 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof |
| 07/01/2008 | US7393926 kit of parts comprising the MAP-solution, a preparation comprising the periodate ions and optionally a device to apply the compositions of the invention to surfaces that are to be attached to each other or coated |
| 07/01/2008 | US7393925 structural modification alters the biological persistence, preferably the biological half-life |
| 07/01/2008 | US7393924 Smart bio-nanoparticle elements |
| 07/01/2008 | US7393923 Red-shifted fluorescent proteins mPlum and mRaspberry and polynucleotides encoding the same |
| 07/01/2008 | US7393922 Insecticidal Cry4Ba proteins with enhanced toxicity |
| 07/01/2008 | US7393921 Nucleotide sequences coding polypeptide for use diagnosis and treatment of prostate cancer |
| 07/01/2008 | US7393918 Protein binding miniature proteins and uses thereof |
| 07/01/2008 | US7393917 PRO1482 polypeptides |
| 07/01/2008 | US7393837 Method for treating metabolic bone disease such as osteomalacia and osteoporosis in a patient by administering a compound that modulates phosphate regulating endopeptidase homolog (PEX) expression and/or PEX enzymatic activity |
| 07/01/2008 | US7393832 Nucleotide sequences coding membrane proteiin receptor for identifying modulators for prevention and treatment of nervous system, vision and cell proliferative disorders; wound healing agents; |
| 07/01/2008 | US7393831 prophylactic and therapeutic vaccination directed against the hepatitis C virus |
| 07/01/2008 | US7393829 Peptide that inhibits stimulated endothelial cell proliferation |
| 07/01/2008 | US7393824 Methods of peptide preparation |
| 07/01/2008 | US7393823 isolated polypeptide, glycosylated polypeptide and monoclonal antibody and their combinations; binds to the extracellular domain of EGF receptor |
| 07/01/2008 | US7393684 Immunoconjugates of anti-IL-20 antibodies and hybridoma cell lines expressing anti-IL-20 antibodies |
| 07/01/2008 | US7393682 Polynucleotides encoding promyostatin polypeptides |
| 07/01/2008 | US7393679 Enzyme for degrading hyaluronic acid to amino acid; genetic engineered gene |
| 07/01/2008 | US7393675 Nucleotide sequences coding sugar metabolism and oxidative phosphorylation (SMP) protein for preparation and generation of amino acid for use in foods, cosmetics and medicines; bioremediation; terpenoid biosynthesis |
| 07/01/2008 | US7393671 Mutant carotenoid ketolases |
| 07/01/2008 | US7393662 Human EPO mimetic hinge core mimetibodies, compositions, methods and uses |
| 07/01/2008 | US7393661 Nucleic acids encoding OBG3 polypeptides |
| 07/01/2008 | US7393660 Polypeptide of given sequence; transforming or transfecting cell with expression vector; inhibits tumor necrosis factor release; anti-inflammatory |
| 07/01/2008 | US7393657 Diagnosis and treatment of cancer: I |
| 07/01/2008 | US7393655 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder |
| 07/01/2008 | US7393654 Nucleotide sequences coding G-protein coupled receptor (T2R) for use in identifying modulators which control bitterness; food processing and pharmocological design |
| 07/01/2008 | US7393651 Confluence regulated adhesion molecules useful in modulating vascular permeability |
| 07/01/2008 | US7393650 Using hybridoma cells to generate monoclonal antibody specific to 7-transmembrane receptor protein for use in the diagnosis, prevention and treatment of psychological and nervous system disorders |
| 07/01/2008 | US7393637 Methods for detecting cancer and monitoring cancer progression |
| 07/01/2008 | US7393632 Use of multiple recombination sites with unique specificity in recombinational cloning |
| 07/01/2008 | US7393631 From contaminated sample using sodium chloride solution to prevent irreversible binding to hydroxyapatite; eluting and washing; reduces empty capsids and impurities |
| 07/01/2008 | US7393549 Defructosylation method |
| 07/01/2008 | US7393540 Therapeutic peptide for prevention of microorganismal infections; enzyme inhibitors; RNA inteference; antisense agents |
| 07/01/2008 | US7393539 Therapeutic agent for prevention and treatment of bacterial infection; bactericides; genetic vaccines; immunotherapy |
| 07/01/2008 | US7393536 Nucleotide sequences coding streptococcus capsular polysaccharide antigens for use in diagnosis and prevention of infections in mammals; veterinary medicine |
| 07/01/2008 | US7393534 Compositions and methods for immunotherapy of cancer and infectious diseases |
| 07/01/2008 | US7393530 IL-1-like cytokine antibodies |
| 07/01/2008 | US7393523 Peptides for active anti-cytokine immunization |
| 06/26/2008 | WO2008077070A2 Crystal structures of hiv-1 protease inhibitors bound to hiv-1 protease |
| 06/26/2008 | WO2008076933A2 Long acting proteins and peptides and methods of making and using the same |
| 06/26/2008 | WO2008076377A2 Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition |
| 06/26/2008 | WO2008076367A2 Polymer-protein substrates for immunosorbent fluorescence assays |
| 06/26/2008 | WO2008076255A2 Canine thymic stromal lymphopoietin protein and uses thereof |
| 06/26/2008 | WO2008075922A1 Human protooncogene, protein encoded by same, expression vector containing same, and cell transformed by said vector |
| 06/26/2008 | WO2008075589A1 Substance capable of inducing platelet aggregation |
| 06/26/2008 | WO2008075363A1 Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions |
| 06/26/2008 | WO2008075349A1 Therapeutic methods using a thymus peptide |
| 06/26/2008 | WO2008075345A2 An apo-ferredoxin preparation, a process for producing same and uses thereof |
| 06/26/2008 | WO2008075174A2 Lysosomal associated membrane protein (lamp) - like polypeptide, ligands to the same, and use of the same in the frame of detection and purification of human plasmacytoid dendritic cells |
| 06/26/2008 | WO2008075045A1 Binding agents to the integrin alpha-11 subunit, and uses thereof |
| 06/26/2008 | WO2008074872A1 Pharmaceutical composition, use of the pharmaceutical composition for treating a brain tumor, production process thereof and a kit of parts comprising the pharmaceutical composition |
| 06/26/2008 | WO2008074863A1 Interleukin-21 variants with altered binding to the il-21 receptor |
| 06/26/2008 | WO2008074813A2 Optiogenin for the treatment of neural diseases |
| 06/26/2008 | WO2008074424A2 Coding genes with a single exon for new bioactive peptides |
| 06/26/2008 | WO2008074356A1 Protein composition for inducing an immune response in a vertebrate comprising a plurality of protein variants covering the heterogeneity of a single antigen, ama1 |
| 06/26/2008 | WO2008074346A2 Chimeric dna polymerase |
| 06/26/2008 | WO2008074230A1 Interferon alpha mutant and its polyethylene glycol derivative |
| 06/26/2008 | WO2008074083A1 Extracting and purifying lipoxygenase |
| 06/26/2008 | WO2008074079A1 Identification of candidate vaccine antigens from dichelobacter nodosus |
| 06/26/2008 | WO2008046228A8 Compounds for stimulating p-glycoprotein function and uses thereof |
| 06/26/2008 | WO2008033451A3 Protein aggregation domains from prions and methods of use thereof |
| 06/26/2008 | WO2008031430A3 Doubly transgenic non-human mammal |
| 06/26/2008 | WO2008016604A3 Use of colostrinin, constituent peptides thereof, and analogs thereof as anti-mutagenic agents |
| 06/26/2008 | WO2008015580A3 Pharmaceutical composition for alleviation and treatment of ischemic conditions and method for delivering the same |
| 06/26/2008 | WO2008012747A3 Process for the manufacture of fluorinated surfactants |
| 06/26/2008 | WO2008011584A3 Bacillus thuringiensis toxin with anti-lepidopteran activity |
| 06/26/2008 | WO2008001109A3 Method of covalently linking a carbohydrate or polyalkylene oxide to a peptide, precursors for use in the method and resultant products |
| 06/26/2008 | WO2007132481A3 Novel thrombolytic molecules and a process therefor |
| 06/26/2008 | WO2007130154A3 Recombinant production of heparin binding proteins |
| 06/26/2008 | WO2007120120A3 Attenuated human parainfluenza virus, methods and uses thereof |
| 06/26/2008 | WO2007113009A8 Ompa polypeptides of rickettsia helvetica, polynucleotides encoding therefor and use in the detection of rickettsia helvetica |
| 06/26/2008 | WO2007109299A3 Peptide |
| 06/26/2008 | WO2007070488A3 Integrin alpha l i domain mutants with increased binding affinity |
| 06/26/2008 | WO2007068736A3 New chemokine antagonists |
| 06/26/2008 | WO2007013807A9 Targeting-enhanced activation of galectins |
| 06/26/2008 | US20080155717 Polycomb genes from maize - mez1 and mez2 |
| 06/26/2008 | US20080155716 Serine hydroxymethyltransferase as target for herbicides |
| 06/26/2008 | US20080155715 Stress-Responsive Root-Specific Genes |
| 06/26/2008 | US20080155714 oil producing crop plant is produced by transfecting; efficient production of cyclopropane fatty acids in an oilseed crop; forming biodegradable lubricants from plant oil; intermediates to branched fatty acids with the low temperature properties and resist to oxidation |
| 06/26/2008 | US20080155703 Identifying new immunomodulatory chemical entities (NICE); reacting a candidate NICE with a Tat SH3 binding domain, identifying the bound candidate NICE and determining whether it induces monocytes to differentiate into dendritic cells (DC) or regulatory macrophages (AReg); drug screening; immunotherapy |
| 06/26/2008 | US20080154386 Method of making demineralized bone particles |
| 06/26/2008 | US20080154025 Fc Variants with Increased Affinity for FcyRIIc |
| 06/26/2008 | US20080154024 ferritin is selectively arranged on a part including titanium or silicon nitride (SiN) in an efficient manner by adding a nonionic surface active agent |
| 06/26/2008 | US20080154022 Transport of basic fibroblast growth factor across the blood brain barrier |
| 06/26/2008 | US20080153979 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
| 06/26/2008 | US20080153759 Treatment methods using polypeptides related to amyloid precursor protein |
| 06/26/2008 | US20080153756 Nucleic acids encoding them; for use in modulating alpha 4 integrin function; kits; antibodies against the peptides |